secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001214659-23-012218
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro enters ATM equity facility for up to $9.8M with Ascendiant Capital
--------------------------------------------------------------------------------

- Entered Sales Agreement with Ascendiant Capital Markets for at-the-market issuance of common stock up to $9.8M.
- Shares sold from time to time under effective shelf registration statement (File No. 333-273610) declared effective Aug 10, 2023.
- Agent will use commercially reasonable efforts; Company sets parameters like number, time, and minimum price.
- Either party may terminate agreement at any time upon written notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923012218/0001214659-23-012218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923012218/z972308k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-012218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer